Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening.
Future Med Chem
; 14(2): 61-79, 2022 01.
Article
in English
| MEDLINE | ID: covidwho-1534390
ABSTRACT
Background:
Conserved domains within SARS-CoV-2 nonstructural proteins represent key targets for the design of novel inhibitors.Methods:
The authors aimed to identify potential SARS-CoV-2 NSP5 inhibitors using the ZINC database along with structure-based virtual screening and molecular dynamics simulation.Results:
Of 13,840 compounds, 353 with robust docking scores were initially chosen, of which ten hit compounds were selected as candidates for detailed analyses. Three compounds were selected as coronavirus NSP5 inhibitors after passing absorption, distribution, metabolism, excretion and toxicity study; root and mean square deviation; and radius of gyration calculations.Conclusion:
ZINC000049899562, ZINC000169336666 and ZINC000095542577 are potential NSP5 protease inhibitors that warrant further experimental studies.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Protease Inhibitors
/
Coronavirus 3C Proteases
/
SARS-CoV-2
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
Future Med Chem
Year:
2022
Document Type:
Article
Affiliation country:
Fmc-2020-0380
Similar
MEDLINE
...
LILACS
LIS